Article
MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome.
The pharmacogenomics journal - 1 Feb 2010
Cizmarikova M, Wagnerova M, Schonova L, Habalova V, Kohut A, Linkova A, Sarissky M, Mojzis J, Mirossay L, Mirossay A
Abstract excerpt
P-glycoprotein (PGP), the product of the MDR1 gene, is a transmembrane active efflux pump for a variety of carcinogens and cytostatics. It has been suggested that MDR1 polymorphisms contribute to the variability in cancer risk and therapeutic outcome. We examined the relevance of C3435T polymorphism in relation to breast cancer susceptibility, clinical and pathological characteristics of breast carcinoma, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
